Human IgG antibody Laboratories manufactures the elisa using tumor lysates reagents distributed by Genprice. The Elisa Using Tumor Lysates reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact tumor elisa. Other Elisa products are available in stock. Specificity: Elisa Category: Using Group: Tumor Lysates
Tricostatin A (TSA) Treated And Untreated Cell Lysates |
Cytoskeleton |
100 µg treated + 100 µg untreated |
EUR 107.12 |
Tumor Lysates information
Rabbit polyclonal using eIF2 alpha (Ser51) antibody(Phospho-specific) |
TA312128 |
Origene Technologies GmbH |
100 µl |
Ask for price |
Skin Tumor Lysate |
1337 |
ProSci |
0.1 mg |
EUR 304.8 |
Description: Skin tumor tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
Skin Tumor Lysate |
MBS151601-01mg |
MyBiosource |
0.1mg |
EUR 260 |
Skin Tumor Lysate |
MBS151601-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1140 |
Lung Tumor Lysate |
MBS151668-01mg |
MyBiosource |
0.1mg |
EUR 260 |
Lung Tumor Lysate |
MBS151668-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1140 |
Liver Tumor Lysate |
1330 |
ProSci |
0.1 mg |
EUR 304.8 |
Description: Liver tumor tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
Liver Tumor Lysate |
MBS151608-01mg |
MyBiosource |
0.1mg |
EUR 260 |
Liver Tumor Lysate |
MBS151608-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1140 |
Brain Tumor Lysate |
MBS151610-01mg |
MyBiosource |
0.1mg |
EUR 260 |
Brain Tumor Lysate |
MBS151610-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1140 |
Ovary Tumor Lysate |
MBS151654-01mg |
MyBiosource |
0.1mg |
EUR 260 |
Ovary Tumor Lysate |
MBS151654-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1140 |
Colon Tumor Lysate |
MBS151700-01mg |
MyBiosource |
0.1mg |
EUR 260 |
Colon Tumor Lysate |
MBS151700-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1140 |
Rectum Tumor Lysate |
1336 |
ProSci |
0.1 mg |
EUR 304.8 |
Description: Rectum tumor tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
Spleen Tumor Lysate |
1339 |
ProSci |
0.1 mg |
EUR 304.8 |
Description: Spleen tumor tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |